GlassScriptPhysician profile
Zakir M Ali
NPI 1699727750
$8,236.76
in general payments reported to CMS, 2019-2025
42 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $586 · 2021: $675 · 2022: $1,558 · 2023: $1,150 · 2024: $1,748 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,189 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,189.15 |
| Education | $132.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $951.14 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Alexion Pharmaceuticals, INC. | $802.70 | 2019-2025 | Ultomiris |
| Biogen, INC. | $735.06 | 2019-2024 | Vumerity, Tysabri |
| Abbvie INC. | $627.03 | 2019-2025 | Qulipta |
| Genzyme Corporation | $590.23 | 2019-2023 | |
| Csl Behring | $495.00 | 2019-2025 | Hizentra |
| Sunovion Pharmaceuticals INC. | $358.13 | 2019-2022 | |
| Tg Therapeutics, INC. | $339.30 | 2024-2025 | |
| Ucb, INC. | $318.20 | 2020-2025 | Cimzia, Bimzelx, Nayzilam |
| Celgene Corporation | $296.43 | 2022 | |
| Genentech USA, INC. | $230.92 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Sumitomo Pharma America, INC. | $221.79 | 2023-2024 | Aptiom |
| Sk Life Science, INC. | $216.65 | 2022-2025 | Xcopri |
| Emd Serono, INC. | $210.09 | 2019-2025 | |
| Eisai INC. | $176.05 | 2023-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zakir Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.